Document Detail


New therapeutic aspects of inflammatory cardiomyopathy.
MedLine Citation:
PMID:  25483946     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Inflammatory cardiomyopathy is a term used for left ventricular systolic dysfunction associated with myocarditis. In order to establish definitely the diagnosis, an endomyocardial biopsy (EMB) must be performed. Based on the results of EMB analysis, specific treatment may be added to conventional heart failure therapy. Immunosuppressive therapy in patients with non-viral inflammatory cardiomyopathy has been shown to be effective, and there is also some evidence that antiviral or antimicrobial therapy may be beneficial.
Authors:
Petr Kuchynka; Tomas Palecek; Eduard Nemecek; Michal Fikrle; Ales Linhart
Related Documents :
22254646 - Image-based estimation of ventricular fiber orientations for patient-specific simulations.
25262686 - Catheter ablation of atrial fibrillation in patients with left ventricular systolic dys...
22758616 - The role of transesophageal echocardiography in the intraoperative period.
25441826 - Beating-heart surgery for hypoplastic left heart syndrome with coronary artery fistulas.
6976206 - Predictive value of symptom-limited exercise for risk assessment of primary and seconda...
11359746 - An echocardiographic assessment of cardiac morphology and common ecg findings in teenag...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current pharmaceutical design     Volume:  21     ISSN:  1873-4286     ISO Abbreviation:  Curr. Pharm. Des.     Publication Date:  2014  
Date Detail:
Created Date:  2014-12-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  459-65     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacotherapy of dilated cardiomyopathy.
Next Document:  Mechanisms and medical management of exercise intolerance in hypertrophic cardiomyopathy.